Therapeutic Solutions International, Inc. (TSOI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Apr 25, 2025, 4:00 PM EDT
TSOI Revenue
Therapeutic Solutions International had revenue of $19.67K in the quarter ending September 30, 2024, a decrease of -23.56%. This brings the company's revenue in the last twelve months to $85.32K, up 1.89% year-over-year. In the year 2023, Therapeutic Solutions International had annual revenue of $98.99K, down -52.12%.
Revenue (ttm)
85.32K
Revenue Growth
+1.89%
P/S Ratio
6.91
Revenue / Employee
28.44K
Employees
3
Market Cap
589.22K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 98.99K | -107.77K | -52.12% |
Dec 31, 2022 | 206.77K | 60.81K | 41.66% |
Dec 31, 2021 | 145.96K | 83.28K | 132.86% |
Dec 31, 2020 | 62.68K | 35.19K | 127.97% |
Dec 31, 2019 | 27.50K | 24.01K | 689.18% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Therapeutic Solutions International News
- 5 days ago - Therapeutic Solutions International to Voluntarily Delist - Business Wire
- 1 year ago - Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases - Business Wire
- 1 year ago - Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients - Business Wire
- 1 year ago - Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product - Business Wire
- 1 year ago - Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation - Business Wire
- 1 year ago - Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities - Business Wire
- 1 year ago - Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy - Business Wire
- 1 year ago - Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™ - Business Wire